Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective...
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review
About this item
Full title
Author / Creator
Chan, David L. , Bergsland, Emily K. , Chan, Jennifer A. , Gadgil, Rujuta , Halfdanarson, Thorvardur R. , Hornbacker, Kathleen , Kelly, Virginia , Kunz, Pamela L. , McGarrah, Patrick W. , Raj, Nitya P. , Reidy, Diane L. , Thawer, Alia , Whitman, Julia , Wu, Linda , Becker, Christoph and Singh, Simron
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
Grade 3 gastroenteropancreatic neuroendocrine neoplasms (G3 GEPNENs) are often aggressive, and the optimal treatment is unclear for this subgroup of neuroendocrine neoplasms (NENs). Temozolomide (TEM)‐based regimens have been increasingly used to treat grade 1–2 NENs, but their efficacy in G3 NENs remains undetermined. We aimed to ass...
Alternative Titles
Full title
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8571741
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8571741
Other Identifiers
ISSN
1083-7159
E-ISSN
1549-490X
DOI
10.1002/onco.13923
